• Shareholders that lost money on Altimmune, Inc.(ALT) should contact Levi & Korsinsky about pending Class Action - ALT ACCESS Newswire Mon, 05 May 2025 01:24:57 GMT
• lost money on altimmune, inc.(alt)? join class action suit seeking recovery - contact levi & korsinsky ACCESS Newswire Sun, 04 May 2025 18:59:52 GMT
• Altimmune, Inc. to Showcase Novel MASH Resolution Index Data for Pemvidutide at EASL International Liver Congress™ 2025 Nasdaq Thu, 01 May 2025 11:42:00 GMT
• Altimmune to Present at Upcoming EASL International Liver Congress™ 2025 Stock Titan Thu, 01 May 2025 11:30:00 GMT
• Altimmune to Participate in the Citizens Life Sciences Conferenc GuruFocus Wed, 30 Apr 2025 14:28:24 GMT
• Late-Stage Biotech Altimmune Sets Key Fireside Chat: What Investors Should Watch For Stock Titan Wed, 30 Apr 2025 11:30:00 GMT
• Will Pfizer Acquire Altimmune or Viking Therapeutics After Its Obesity Pill Setback? Yahoo Finance Wed, 30 Apr 2025 08:51:00 GMT
• Will Pfizer Will Acquire Altimmune or Viking Therapeutics After Its Obesity Pill Setback? AOL.com Wed, 30 Apr 2025 08:51:00 GMT
• Levi & Korsinsky Notifies Shareholders of Altimmune, Inc.(ALT) of a Class Action Lawsuit and an Upcoming Deadline ACCESS Newswire Sat, 26 Apr 2025 17:44:14 GMT
• After losing 30% in the past year, Altimmune, Inc. (NASDAQ:ALT) institutional owners must be relieved by the recent gain simplywall.st Sat, 26 Apr 2025 12:48:19 GMT
• Citizens JMP maintains Altimmune stock with $25 target Investing.com Wed, 23 Apr 2025 07:00:00 GMT
• corebridge financial inc. sells 2,665 shares of altimmune, inc. (nasdaq:alt) Defense World Sat, 12 Apr 2025 08:11:46 GMT
• nasal vaccines market top companies study - vaxart, inc, flugen inc, altimmune, inc, sinovac biotech ltd. openPR.com Fri, 11 Apr 2025 10:22:00 GMT
• Altimmune's US$42m Market Cap Fall Books Insider Losses Yahoo Finance Thu, 10 Apr 2025 07:00:00 GMT
• Coulter Partners places seasoned biopharmaceutical industry executives to Altimmune Board of Directors Hunt Scanlon Media Wed, 09 Apr 2025 21:53:23 GMT
• altimmune’s swot analysis: pemvidutide potential drives stock outlook by investing.com Investing.com Canada Wed, 09 Apr 2025 03:22:19 GMT
• altimmune’s swot analysis: pemvidutide potential drives stock outlook Investing.com Tue, 08 Apr 2025 20:02:08 GMT
• pharmathene stock plunges to 52-week low of $3.74 amid market challenges Investing.com India Tue, 08 Apr 2025 19:20:56 GMT
• Altimmune's SWOT analysis: pemvidutide potential drives stock outlook Investing.com Tue, 08 Apr 2025 07:00:00 GMT
• levi & korsinsky announces the filing of a securities class action on behalf of altimmune, inc.(alt) shareholders ACCESS Newswire Sun, 06 Apr 2025 17:41:56 GMT
• commonwealth equity services llc has $621,000 stake in altimmune, inc. (nasdaq:alt) Defense World Fri, 04 Apr 2025 07:28:19 GMT
• H.C. Wainwright maintains Buy rating on Altimmune stock Investing.com Fri, 04 Apr 2025 07:00:00 GMT
• altimmune shares sink this year, but retail traders see a buyout on the horizon MSN Thu, 03 Apr 2025 13:47:45 GMT
• Altimmune’s Pemvidutide: A Promising Catalyst with Blockbuster Potential and Strong Financial Backing TipRanks Thu, 03 Apr 2025 07:00:00 GMT
• JMP maintains Altimmune stock target at $25 on Phase 2b optimism Investing.com Wed, 02 Apr 2025 07:00:00 GMT
• altimmune shares sink this year, but retail traders see a buyout on the horizon MSN Tue, 01 Apr 2025 11:32:11 GMT
• altimmune, inc. (alt) investigation: bronstein, gewirtz & grossman, llc encourages investors to seek compensation for alleged wron... ACCESS Newswire Mon, 31 Mar 2025 07:35:27 GMT
• pharmathene stock hits 52-week low at $5.1 amid challenges Investing.com Mon, 31 Mar 2025 07:00:00 GMT
• class action filed against altimmune, inc. (alt) seeking recovery for investors - contact levi & korsinsky ACCESS Newswire Fri, 28 Mar 2025 05:26:42 GMT
• altimmune’s strategic positioning and promising future in obesity and mash treatment markets TipRanks Mon, 24 Mar 2025 07:00:00 GMT
• Buying These Dirt-Cheap Stocks Could Be a Brilliant Move The Motley Fool Sat, 22 Mar 2025 07:00:00 GMT
• Altimmune, Inc. (ALT): The Best Short Squeeze Stock to Buy According to Analysts Insider Monkey Wed, 19 Mar 2025 07:00:00 GMT
• 10 best short squeeze stocks to buy according to analysts Insider Monkey Wed, 19 Mar 2025 06:58:28 GMT
• altimmune shares sink this year, but retail traders see a buyout on the horizon MSN Wed, 19 Mar 2025 06:18:20 GMT
• Altimmune Shares Sink This Year, But Retail Traders See A Buyout On The Horizon MSN Tue, 18 Mar 2025 07:00:00 GMT
• altimmune’s pemvidutide: a promising best-in-class therapy with broad potential and strong buy rating TipRanks Tue, 18 Mar 2025 07:00:00 GMT
• altimmune to test obesity drug for alcohol use disorder and related health conditions MSN Mon, 17 Mar 2025 22:53:21 GMT
• alt lawsuit alert: levi & korsinsky notifies altimmune, inc. investors of a class action lawsuit and upcoming deadline ACCESS Newswire Mon, 17 Mar 2025 14:33:09 GMT
• altimmune’s promising r&d developments and market opportunities drive buy rating TipRanks Mon, 17 Mar 2025 13:24:40 GMT
• Altimmune Jumps On Takeover Rumors After Launching Alcohol Use Disorder Study BioSpace Mon, 17 Mar 2025 07:00:00 GMT
• Altimmune: Pemvidutide Differentiation Advancement In MASH Space Continues To Shine (ALT) Seeking Alpha Mon, 17 Mar 2025 07:00:00 GMT
• altimmune’s swot analysis: pemvidutide’s potential reshapes obesity and mash stock outlook Investing.com Mon, 17 Mar 2025 07:00:00 GMT
• altimmune call volume above normal and directionally bullish TipRanks Mon, 17 Mar 2025 07:00:00 GMT
• altimmune to test obesity drug for alcohol use disorder and related health conditions MSN Sun, 16 Mar 2025 04:50:12 GMT
• altimmune cfo gregory weaver purchases $51,996 in stock by investing.com Investing.com Australia Sat, 15 Mar 2025 04:43:18 GMT
• Altimmune Outlines Pemvidutide Plans In MASH And Beyond insights.citeline.com Fri, 14 Mar 2025 21:25:46 GMT
• altimmune call volume above normal and directionally bullish TipRanks Fri, 14 Mar 2025 19:05:10 GMT
• altimmune rises on plans to test obesity drug for alcohol use disorder, other conditions TradingView Fri, 14 Mar 2025 12:29:47 GMT
• Altimmune to study obesity drug in alcohol use disorder, following Eli Lilly statnews.com Fri, 14 Mar 2025 07:00:00 GMT
• Altimmune To Test Investigational GLP-1–Based Obesity Drug for Alcohol Use Disorder BioSpace Fri, 14 Mar 2025 07:00:00 GMT
• Altimmune stock rises amid buyout and R&D news(ALT:NASDAQ) Seeking Alpha Fri, 14 Mar 2025 07:00:00 GMT
• Citizens JMP reiterates Altimmune stock with $25 target Investing.com Fri, 14 Mar 2025 07:00:00 GMT
• Stifel maintains Buy on Altimmune stock, $18 price target Investing.com Fri, 14 Mar 2025 07:00:00 GMT
• Altimmune CFO Gregory Weaver purchases $51,996 in stock Investing.com Fri, 14 Mar 2025 07:00:00 GMT
• Altimmune Expands Weight-Loss Drug Pemvidutide's Potential To Alcohol-Related Disorders Benzinga Fri, 14 Mar 2025 07:00:00 GMT
• Altimmune to put its incretin into addiction trials; Tarsus aims to raise $125M Endpoints News Fri, 14 Mar 2025 07:00:00 GMT
• evercore bullish on altimmune, likes drug move into alcohol related disease TipRanks Fri, 14 Mar 2025 07:00:00 GMT
• promising potential of altimmune’s pemvidutide drives buy rating amid expanding indications and strong market outlook TipRanks Fri, 14 Mar 2025 05:41:23 GMT
• altimmune to test obesity drug for alcohol use disorder and related health conditions MSN Fri, 14 Mar 2025 01:47:00 GMT
• altimmune to test obesity drug for alcohol use disorder and related health conditions MSN Thu, 13 Mar 2025 23:56:24 GMT
• altimmune gains on plans to test weight-loss drug for alcohol use disorder, other conditions TradingView Thu, 13 Mar 2025 21:01:41 GMT
• promising potential of altimmune’s pemvidutide drives buy rating amid expanding indications and strong market outlook TipRanks Thu, 13 Mar 2025 07:00:00 GMT
• sbi securities co. ltd. acquires new shares in altimmune, inc. (nasdaq:alt) Defense World Wed, 12 Mar 2025 11:11:52 GMT
• altimmune at leerink’s global healthcare conference: strategic insights on pemvidutide Investing.com Australia Tue, 11 Mar 2025 02:47:29 GMT
• altimmune at leerink’s global healthcare conference: strategic insights on pemvidutide Investing.com Mon, 10 Mar 2025 07:00:00 GMT
• rhumbline advisers has $756,000 stake in altimmune, inc. (nasdaq:alt) Defense World Fri, 07 Mar 2025 09:36:36 GMT
• hc wainwright has bearish estimate for altimmune q2 earnings Defense World Fri, 07 Mar 2025 07:07:10 GMT
• Can Altimmune's Pemvidutide Transform Both Obesity and MASH Treatment? R&D Day to Reveal Full Potential Stock Titan Thu, 06 Mar 2025 08:00:00 GMT
• Altimmune, Inc. Announces Virtual R&D Day Focused on Pemvidutide Development and Upcoming Trial Data Nasdaq Thu, 06 Mar 2025 08:00:00 GMT
• altimmune fy2029 eps forecast decreased by hc wainwright Defense World Thu, 06 Mar 2025 07:23:37 GMT
• altimmune, inc. class action: levi & korsinsky reminds altimmune investors of the pending class action lawsuit with a lead plainti... ACCESS Newswire Wed, 05 Mar 2025 13:49:54 GMT
• shareholders of altimmune, inc. should contact levi & korsinsky before july 5, 2024 to discuss your rights - alt ACCESS Newswire Wed, 05 Mar 2025 13:29:43 GMT
• H.C. Wainwright maintains Altimmune stock Buy rating, $12 target Investing.com Tue, 04 Mar 2025 08:00:00 GMT
• altimmune (nasdaq:alt) receives “buy” rating from hc wainwright Defense World Tue, 04 Mar 2025 07:06:08 GMT
• lost money on altimmune, inc.(alt)? join class action suit seeking recovery - contact levi & korsinsky ACCESS Newswire Tue, 04 Mar 2025 03:55:27 GMT
• lost money on altimmune, inc. (alt)? join class action suit seeking recovery - contact levi & korsinsky ACCESS Newswire Mon, 03 Mar 2025 08:11:31 GMT
• b. riley has optimistic outlook of altimmune fy2025 earnings Defense World Mon, 03 Mar 2025 08:00:31 GMT
• how will altimmune's upcoming leerink conference appearance impact its clinical pipeline strategy? Stock Titan Mon, 03 Mar 2025 08:00:00 GMT
• altimmune to participate in the leerink global healthcare conference Yahoo Finance Mon, 03 Mar 2025 08:00:00 GMT
• altimmune stock: a deep dive into analyst perspectives (4 ratings) Benzinga Mon, 03 Mar 2025 08:00:00 GMT
• altimmune’s pemvidutide: promising future with impact trial and market expansion TipRanks Mon, 03 Mar 2025 08:00:00 GMT
• altimmune, inc. (nasdaq: alt) investor alert: bernstein liebhard llp announces that a securities class action lawsuit has been fil... ACCESS Newswire Sun, 02 Mar 2025 22:06:58 GMT
• levi & korsinsky notifies shareholders of altimmune, inc.(alt) of a class action lawsuit and an upcoming deadline ACCESS Newswire Sun, 02 Mar 2025 22:02:27 GMT
• william blair begins coverage on altimmune (nasdaq:alt) Defense World Sun, 02 Mar 2025 08:00:00 GMT
• altimmune inc (alt) q4 2024 earnings call highlights: strategic advances amid rising r&d costs GuruFocus.com Sat, 01 Mar 2025 09:24:46 GMT
• brokerages set altimmune, inc. (nasdaq:alt) target price at $20.83 MarketBeat Sat, 01 Mar 2025 05:37:26 GMT
• william blair initiates coverage of altimmune (alt) with market perform recommendation Nasdaq Sat, 01 Mar 2025 00:06:00 GMT
• altimmune (nasdaq:alt) releases earnings results, beats estimates by $0.01 eps MarketBeat Fri, 28 Feb 2025 21:48:38 GMT
• william blair initiates coverage of altimmune (lse:0a4c) with market perform recommendation Nasdaq Fri, 28 Feb 2025 17:37:00 GMT
• Altimmune Full Year 2024 Earnings: Revenues Beat Expectations, EPS In Line simplywall.st Fri, 28 Feb 2025 12:28:28 GMT
• altimmune, inc. sued for securities law violations - investors should contact levi & korsinsky for more information - alt ACCESS Newswire Fri, 28 Feb 2025 09:42:57 GMT
• William Blair Initiates Coverage of Altimmune (ALT) with Market Perform Recommendation Nasdaq Fri, 28 Feb 2025 08:00:00 GMT
• Altimmune Q4 Earnings Review: The Big News Is The MASH With Obesity Data Readout Due In Q2 Seeking Alpha Fri, 28 Feb 2025 08:00:00 GMT
• this costar group analyst begins coverage on a bullish note; here are top 5 initiations for friday Benzinga Fri, 28 Feb 2025 08:00:00 GMT
• altimmune, inc. (nasdaq:alt) q4 2024 earnings call transcript Insider Monkey Fri, 28 Feb 2025 08:00:00 GMT
• william blair initiates altimmune at market perform -february 28, 2025 at 07:51 am est Marketscreener.com Fri, 28 Feb 2025 08:00:00 GMT
• investors in altimmune, inc. should contact levi & korsinsky before july 5, 2024 to discuss your rights - alt ACCESS Newswire Fri, 28 Feb 2025 07:36:01 GMT
• altimmune inc (alt) q4 2024 earnings call highlights: strategic advances amid rising r&d costs Yahoo Fri, 28 Feb 2025 07:13:15 GMT
• altimmune retail buzz heats up on mash progress, fda nod for new trials: stock jumps after q4 print MSN Fri, 28 Feb 2025 07:06:54 GMT
• altimmune reports progress in clinical trials and financials TipRanks Fri, 28 Feb 2025 05:14:41 GMT
• shareholders that lost money on altimmune, inc. (alt) urged to join class action - contact levi & korsinsky to learn more ACCESS Newswire Fri, 28 Feb 2025 05:08:46 GMT
• shareholders that lost money on altimmune, inc.(alt) urged to join class action - contact levi & korsinsky to learn more ACCESS Newswire Fri, 28 Feb 2025 02:40:27 GMT
• altimmune, inc. (alt) investigation: bronstein, gewirtz & grossman, llc encourages investors to seek compensation for alleged wron... ACCESS Newswire Thu, 27 Feb 2025 23:01:38 GMT
• levi & korsinsky reminds altimmune investors of the pending class action lawsuit with a lead plaintiff deadline of july 5, 2024 - ... ACCESS Newswire Thu, 27 Feb 2025 22:47:45 GMT
• shareholders that lost money on altimmune, inc.(alt) urged to join class action - contact levi & korsinsky to learn more ACCESS Newswire Thu, 27 Feb 2025 10:08:01 GMT
• Can Altimmune's $131.9M War Chest Fuel Its Pemvidutide Program Through Critical MASH Readout? Stock Titan Thu, 27 Feb 2025 08:00:00 GMT
• Altimmune Announces Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update Yahoo Finance Thu, 27 Feb 2025 08:00:00 GMT
• Altimmune Reports Progress in Clinical Trials and Financials TipRanks Thu, 27 Feb 2025 08:00:00 GMT
• earnings call transcript: altimmune q4 2024 sees stock surge 7.41% Investing.com Thu, 27 Feb 2025 08:00:00 GMT
• altimmune retail buzz heats up on mash progress, fda nod for new trials: stock jumps after q4 print MSN Thu, 27 Feb 2025 08:00:00 GMT
• altimmune earnings beat by $0.01, revenue fell short of estimates Investing.com Thu, 27 Feb 2025 08:00:00 GMT
• altimmune earnings results: $alt reports quarterly earnings Quiver Quantitative Thu, 27 Feb 2025 08:00:00 GMT
• altimmune’s innovative approach to mash and obesity: a promising future with pemvidutide TipRanks Thu, 27 Feb 2025 08:00:00 GMT
• altimmune files for mixed shelf offering of up to $400 million- sec filing -february 27, 2025 at 05:34 pm est Marketscreener.com Thu, 27 Feb 2025 08:00:00 GMT
• upcoming alt deadline: bronstein, gewirtz & grossman llc reminds altimmune, inc. investors to join the class action lawsuit! ACCESS Newswire Thu, 27 Feb 2025 05:02:28 GMT
• Seasoned Biopharmaceutical Industry Executives Teri Lawver and Jerry Durso Appointed to Altimmune Board of Directors Yahoo Finance Tue, 25 Feb 2025 08:00:00 GMT
• can these two industry veterans transform altimmune's commercial future? key appointments signal major shift Stock Titan Tue, 25 Feb 2025 08:00:00 GMT
• teri lawver and jerry durso appointed to altimmune board of directors citybiz Tue, 25 Feb 2025 08:00:00 GMT
• altimmune, inc. expands board of directors with appointments of teri lawver and jerry durso Quiver Quantitative Tue, 25 Feb 2025 08:00:00 GMT
• investors in altimmune, inc. should contact levi & korsinsky before july 5, 2024 to discuss your rights - alt ACCESS Newswire Sun, 23 Feb 2025 15:46:27 GMT
• altimmune (nasdaq:alt) trading 8.7% higher - time to buy? MarketBeat Sun, 23 Feb 2025 08:00:00 GMT
• levi & korsinsky reminds altimmune, inc. investors of the pending class action lawsuit with a lead plaintiff deadline of july 5, 2... ACCESS Newswire Thu, 20 Feb 2025 13:04:45 GMT
Altimmune, Inc(NASDAQ:ALT) 
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing intranasal vaccines, immune modulating therapies, and treatments for liver disease. The company develops AdCOVID, a single-dose intranasal vaccine that is in Phase I clinical trial to protect against COVID-19; T-COVID...
Website: http://www.altimmune.com
Founded: 1997
Full Time Employees: 25
Sector: Healthcare
Industry: Biotechnology